Keywords: aHUS, atypical hemolytic uremic syndrome; AP, alternative complement pathway; ELISA, enzyme-linked immunosorbent assay; ESRD, end-stage renal disease; CKD, chronic kidney disease; FB, factor B; FH, factor H; FI, factor I; MODS, multiple organ dysfunction
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator
Keywords: Complement factor H; Atypical haemolytic uremic syndrome; Anti-factor H autoantibodies; Complement factor I deficiency.FH, factor H; FI, factor I; aHUS, atypical haemolytic uremic syndrome; CFHRs, factor H related proteins
Putting the structure into complement
Keywords: MAC, membrane attack complex; FH, factor H; FI, factor I; FD, factor D; FB, factor B; MBL, mannose binding lectin; MACPF, membrane attack complex/perforin domain; CDC, cholesterol dependent cytolysinComplement; Structure; Regulation; Protein complexes
Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency
Keywords: C3, third complement factor; C4BP, C4b-binding protein; CR1, complement receptor 1; FB, Factor B; FH, Factor H; FI, Factor I; FIMAC, Factor I membrane attack complex; JIA, juvenile idiopathic arthritis; LDLr, low density lipoprotein receptor; MCP, membran
The effect of electrostatics on factor H function and related pathologies
Keywords: FH, Factor H; C3, complement system protein C3; C3b, the b-fragment of C3; CCP, complement control protein; MG, macroglobulin (referring to the α2-MG family); FB, Factor B; Bb, the b-fragment of FB; FI, Factor I; GAG, glycosaminoglycan; SNP, single nucleo
Complement factor I in health and disease
Keywords: aHUS, atypical hemolytic uremic syndrome; C4BP, C4b-binding protein; CFI, complement factor I gene; CR1, complement receptor 1; DFP, diisopropylfluorophosphate; ESRD, end-stage renal disease; FH, Factor H; FI, Factor I; FIMAC, factor I membrane attack com
Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b
Keywords: C3, complement component 3; SCIN, staphylococcal complement inhibitor; fH, factor H; fI, factor I; RCSB, Research Collaboratory for Structural Bioinformatics; SPR, surface plasmon resonance; CVF, cobra venom factorcomplement; C3 convertase; immune evasion
Molecular cloning of the terminal complement components C6 and C8β of cartilaginous fish
Keywords: Complement; Evolution; C6; C8β; Shark; Chimaera, cytolytic pathway; Terminal complement componentTCC, Terminal complement component; C3, complement component 3; fB, factor B; MASP, mannan-binding protein-associated serine protease; fI, factor I; MAC, memb
Evolutionary origin of the vertebrate blood complement and coagulation systems inferred from liver EST analysis of lamprey
Keywords: TCC, terminal complement component; fI, factor I; fB, factor B; MASP, mannan-binding protein-associated serine protease; A2M, alpha-2-macroglobulin; FVII, factor VII; FIX, factor IX; FX, factor X; ds, double strand; RACE, rapid amplification of cDNA ends;
Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNA
Keywords: C4BP, C4b-binding protein; FI, factor I; CCP, complement control protein (domain); MAC, membrane attack complex; MCP, membrane cofactor protein; DAF, decay-accelerating factor; CR1, complement receptor 1; FH, factor H; GAG, glycosaminoglycan; HSQC, hetero
Effect of chronic ethanol consumption on the expression of complement components and acute-phase proteins in liver
Keywords: FB, complement factor B; C1qA, complement C1qA-chain; C1qB, complement C1qB-chain; FD, factor D (adipsin); P, properdin; C8α, C8, alpha-chain; C8β, C8, beta-chain; FH, factor H; FI, factor I; C4bp, C4b binding protein; CN, clusterin; VN, vitronectin; DAF,
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation
Keywords: aHUS, atypical hemolytic uremic syndrome; C4BP, C4b-binding protein; CR1, complement receptor 1; FB, factor B; FH, factor H; FI, factor I; FIMAC, factor I membrane attack complex (domain); ESRD, end-stage renal disease; LDLr, low density lipoprotein recep